Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
06/19/1991 | EP0432479A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin |
06/19/1991 | EP0432443A1 Polyester based on 4-hydroxyalkanoic acids and process for their preparation |
06/19/1991 | EP0432431A1 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
06/19/1991 | EP0282495B1 Xylometazolin-containing pharmaceuticals |
06/19/1991 | CA2071958A1 Sustained flavorant release composition, method for making same and chewable structure incorporating same |
06/19/1991 | CA2032373A1 Formulation |
06/18/1991 | US5024997 Aqueous solution with sweetener and cyclodextrin derivate; for oral administration |
06/18/1991 | US5024843 Time-release tablet; unaffected by gastrointestinal environment |
06/18/1991 | US5024834 Thioether linked immunotoxin conjugates |
06/18/1991 | US5024787 Process for the preparation of fatty acid or hydroxy fatty acid esters of isopropylidene derivatives of polyglycerols |
06/16/1991 | WO1991009134A1 Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
06/16/1991 | CA2069439A1 Monoclonal antibodies, their production and use |
06/13/1991 | WO1991008736A1 Plasma-irradiated solid preparation |
06/13/1991 | WO1991008229A1 Hirudine polyalkylene glycol conjugates |
06/13/1991 | WO1991008220A1 A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines |
06/13/1991 | WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
06/13/1991 | WO1991007989A1 A method of inactivating human immunodeficiency virus |
06/13/1991 | WO1991007987A1 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
06/13/1991 | WO1991007974A1 Topical therapeutic preparation |
06/13/1991 | WO1991007951A1 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
06/13/1991 | WO1991007950A1 Pharmaceutical compositions |
06/13/1991 | WO1991007941A2 Methods and compositions for the treatment of hodgkin's disease |
06/13/1991 | CA2042393A1 Plasma-irradiated solid preparation |
06/12/1991 | EP0431942A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative |
06/12/1991 | EP0431877A1 Cimetidine pharmaceutical compositions |
06/12/1991 | EP0431828A1 Improvements relating to the administration of pharmaceutical agents |
06/12/1991 | EP0431759A1 Process for the preparation of a ranitidine resin absorbate |
06/12/1991 | EP0431719A1 Vaginal tissue moisturizing composition |
06/12/1991 | EP0431663A1 Stabilized solutions of psychotropic agents |
06/12/1991 | EP0431659A1 Pharmaceutical compositions of tebufelone |
06/12/1991 | EP0431519A1 System for transdermal albuterol administration |
06/12/1991 | EP0431376A1 Hard confections containing hydrogenated isomaltulose and a medicinally active ingredient |
06/12/1991 | EP0431135A1 Particle-mediated transformation of animal somatic cells |
06/12/1991 | EP0431128A1 Self-assembled, defective, non-self-propagating viral particles |
06/12/1991 | EP0431080A1 Compositions and methods for drug delivery and chromatography |
06/12/1991 | CN1052050A Process for preparing injection agent with high fe content |
06/12/1991 | CN1052046A Pharmaceutical preparations |
06/12/1991 | CN1012819B Process for preparing s-adenosyl-l-methionine and stable salts with polyanions |
06/11/1991 | US5023355 Heating and stirring to disperse in a polysorbate in an inert atmosphere; adding antioxidants and cooling |
06/11/1991 | US5023252 Using heterocyclic oxygen, sulfur, or nitrogen containing compound |
06/11/1991 | US5023251 O/W cream containing hydrocortisone diester |
06/11/1991 | US5023248 Hydroglycemic agents, treatment of hyperketonemia and changes in lipid metabolism |
06/11/1991 | US5023245 Improved niacin formulation |
06/11/1991 | US5023085 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
06/11/1991 | US5023082 Liquid precursor comprising plasticizer, active material, crosslinking agent, water soluble crosslinkable protein; biodegradable |
06/11/1991 | US5023080 Time release protein |
06/11/1991 | US5023078 Plasminogen activator-heparin conjugates |
06/09/1991 | CA2031468A1 Malaria vaccine |
06/08/1991 | CA2005039A1 Pharmaceuticals and apparatus providing diagnosis and selective tissue necrosis |
06/07/1991 | CA2031243A1 Preparation for endermism containing dopamine derivative |
06/06/1991 | DE4014260A1 New hirudin-poly:alkylene glycol conjugate(s) - used as anticoagulants for treatment and prophylaxis of myocardial infarct, arterial occlusion, venous thrombosis and pulmonary embolism |
06/06/1991 | DE3939475A1 Use of specific amine(s), in preventing nitrosamine formation - in body care preparations, cutting fluids and hydraulic oils |
06/06/1991 | CA2031066A1 Pharmaceutical compositions |
06/05/1991 | EP0430539A2 Ocular implants |
06/05/1991 | EP0430474A1 Sustained release compositions for treating periodontal disease |
06/05/1991 | EP0430414A1 Morphine hydrochloride preparation for rectal administration |
06/05/1991 | EP0430287A2 Sustained-release drug dosage units |
06/05/1991 | EP0430200A1 Drug for s.c. or i.m. application containing polypeptides |
06/05/1991 | EP0430149A2 Pharmaceutical preparations |
06/05/1991 | EP0429832A2 Pressed core without sustained drug release, process for its preparation and use of polyhydroxybutyric acid for making such a pressed core |
06/05/1991 | EP0429732A1 Sustained-release compositions containing cation exchange resins and polycarboxylic polymers |
06/05/1991 | CN1051937A Stem cell factor |
06/05/1991 | CA2031376A1 Single layer transdermal drug administration system |
06/04/1991 | US5021570 Aqueous solution containing fat-soluble vitamin K |
06/04/1991 | US5021079 Flat tetrahedronal with iron chloride, preservative for cut flowers |
05/31/1991 | CA2030870A1 Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing |
05/31/1991 | CA2026354A1 Morphine hydrochloride preparation for rectal administration |
05/30/1991 | WO1991007437A2 Improved cd-30 antibodies and fragments thereof |
05/30/1991 | WO1991007190A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
05/30/1991 | WO1991007184A1 SUBSTANTIALLY ANHYDROUS COMPLEXES OF PVP and H2O¿2? |
05/30/1991 | WO1991007172A1 Oral composition for the treatment of inflammatory bowel diseases |
05/30/1991 | WO1991007170A1 Method of producing aqueous mixed-micelle solutions |
05/30/1991 | WO1991007169A1 Glyceryl acetate ointment vehicles |
05/30/1991 | CA2030943A1 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
05/29/1991 | EP0429248A2 Emulsified composition |
05/29/1991 | EP0429225A1 Sustained release compositions for treating periodontal disease |
05/29/1991 | EP0429224A1 Use of monoolein in the treatment of the periodontal pocket |
05/29/1991 | EP0429187A1 Enhanced bioavailability adsorbates |
05/29/1991 | EP0428635A1 Heterologous block oligomers |
05/29/1991 | EP0428520A1 Antimicrobial composition with long-term activity. |
05/28/1991 | US5019563 Pharmaceutical composition |
05/28/1991 | US5019562 Growth inhibiting agent and the use thereof |
05/28/1991 | US5019400 Very low temperature casting of controlled release microspheres |
05/28/1991 | US5019397 Aqueous emulsion for pharmaceutical dosage form |
05/28/1991 | US5019395 Compositions with enhanced penetration |
05/28/1991 | US5019368 Antibody bound to antitumor agent |
05/28/1991 | CA1284507C Melphalan derivatives |
05/25/1991 | WO1991007949A1 Delayed release formulations |
05/23/1991 | CA2069402A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
05/22/1991 | EP0428486A1 Polymyxin conjugates |
05/22/1991 | EP0428402A1 Propellant composition |
05/22/1991 | EP0428352A1 Anti-inflammatory compositions for external use |
05/22/1991 | EP0428188A2 Novel immunoconjugates and methods for their use in tumor therapy |
05/22/1991 | EP0428169A2 Aqueous liquid formulations |
05/22/1991 | EP0427725A1 Water-soluble complexes of pharmaceuticals |
05/22/1991 | CN1051503A Treatment of conditions and disease |
05/21/1991 | US5017693 Immunoconjugates |
05/21/1991 | US5017648 Proteins, glutamic acid-lysine polymer |
05/21/1991 | US5017613 Valproic acid preparations |
05/21/1991 | US5017609 Storage stability, adrenergic blocking agents |